Abstract
There exists a clear link between depression and pain and use of anti-depressants has resulted in an understanding of the pain-relieving effects of these medications. Further, non-pharmacologic psychological interventions remain a mainstay in treating psychological conditions in the pain patient. Consisting of drugs from multiple categories including serotonin-selective reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), and tricyclic antidepressants (TCAs) among others, anti-depressants have variable amount of relief from pain that must be balanced with adverse effects with these medications and various drug-drug interactions. Knowledge of this area is key not only for the board exam but for clinical practice. Questions regarding medications will be present throughout the text, not limited to this chapter alone which focuses more on non-pharmacologic treatments.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Leerman SF, Haythornthwaite J. Psychological evaluation and testing. In: Benzon HT, editor. Essentials of pain medicine. Elsevier; 2018.
Fishbain D, Cutler R, Rosomoff H. Chronic pain associated depression: antecedent or consequence of chronic pain? A review. Clin J Pain. 1997;13(2):116–37.
Francescangeli J, Karamchandani K, Powell M, Bonavia A. The serotonin syndrome: from molecular mechanisms to clinical practice. Int J Mol Sci. 2019;20(9):2288. https://doi.org/10.3390/ijms20092288. Published 2019 May 9.
O’Sullivan C, Froyman C. Nortriptyline safer than amitriptyline? Can Fam Physician. 2018;64(9):634–6.
Dodd S, Malhi GS, Tiller J, et al. A consensus statement for safety monitoring guidelines of treatments for major depressive disorder. Aust N Z J Psychiatry. 2011;45(9):712–25. https://doi.org/10.3109/00048674.2011.595686.
Cymbalta. 2020. http://www.pdr.net.
Gabapentin. 2020. http://www.pdr.net.
Milnacipran. 2020. http://www.pdr.net.
Buproprion. 2020. http://www.pdr.net.
Mirtazipine. 2020. http://www.pdr.net.
Toprak SK, Erdogan E, Azap OK. Mirtazapine-induced thrombocytopenia and neutropenia. Letter to the editor. Turk J Hematol. 2012;29:297–8.
Heikkila H, Heikkila E, Eisemann M. Predictive factors for the outcome of a multidisciplinary pain rehabilitation programme on sick leave and life satisfaction in patients with whiplash trauma and other myofascial pain: a follow up study. Clin Rehabil. 1998;12:487–96.
Al-Quliti KW. Update on neuropathic pain treatment for trigeminal neuralgia. The pharmacological and surgical options. Neurosciences (Riyadh, Saudi Arabia). 2015;20(2):107–14. https://doi.org/10.17712/nsj.2015.2.20140501.
Tse L, et al. Neuroleptic malignant syndrome: a review from a clinically oriented perspective. Curr Neuropharmacol. 2015;13(3):395–406. https://doi.org/10.2174/1570159x13999150424113345.
Naegel S, Obermann M. Topiramate in the prevention and treatment of migraine: efficacy, safety and patient preference. Neuropsychiatr Dis Treat. 2010;6:17–28.
Lunn MPT, Hughes RAC, Wiffen PJ. Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia. 2014. https://www.cochrane.org/CD007115/NEUROMUSC_duloxetine-treating-painful-neuropathy-chronic-pain-or-fibromyalgia. Accessed 2 Sept 2020.
Bonica JJ. The management of pain. In: History of pain concepts and therapies, vol. 1. 2nd ed. London: Lea & Febiger; 1990. p. 7.
Fordyce, W. E. Behavioral Methods in Chronic Pain and Illness, C. V. Mosby, St. Louis. 1976.
Fromm E, Shor RE. Hypnosis: developments in research and new perspectives. Rutgers; 2009. ISBN 978-0-202-36262-5. Accessed 29 Sept 2020.
Kirsch I. Clinical hypnosis as a nondeceptive placebo. In: Kirsch I, Capafons A, Cardeña-Buelna E, Amigó S, editors. Clinical hypnosis and self-regulation: cognitive-behavioral perspectives. Washington: American Psychological Association; 1999. p. 211–25.
Gladding S. Counseling: a comprehensive review. 6th ed. Columbus: Pearson Education Inc.; 2009.
Hayes SC, Strosahl KD, Wilson KG. Acceptance and commitment therapy: the process and practice of mindful change. 2nd ed. New York: Guilford Press; 2012. p. 240.
Andrasik F. What does the evidence show? Efficacy of behavioral treatments for recurrent headaches in adults. Neurol Sci. 2007;28(Suppl 2):S70–7.
Pain and Insomnia-NIH Assessment Panel. Integration of behavioral and relaxation approaches into treatment of chronic pain and insomnia. JAMA. 1996;276:313.
Elkins G, Jensen MP, Patterson DR. Hypnotherapy for the management of chronic pain. Int J Clin Exp Hypn. 2007;55(3):275–87.
Haythornthwaite JA, Heinberg LJ. Psychological intervention in chronic pain. In: Benzon HT, Raja SN, Molloy R, Liu S, Fishman S, editors. Essentials of pain medicine and regional anesthesia. 2nd ed. Philadelphia, PA: Elsevier/Churchill Livingstone; 2005. p. 209–11.
Prochaska JO, DiClemente CC. The transtheoretical approach. In: Norcross JC, Goldfried MR, editors. Handbook of psychotherapy integration. 2nd ed. New York: Oxford University Press; 2005. p. 147–71.
Prochaska JO, DiClemente CC. Toward a comprehensive model of change. In: Miller WR, Heather N, editors. Treating addictive behaviors: processes of change. New York: Plenum Press; 1986. p. 3–27.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2021 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Suer, M., Sehgal, N. (2021). Psychological Interventions and Pharmacology. In: Questions and Answers in Pain Medicine. Springer, Cham. https://doi.org/10.1007/978-3-030-68204-0_7
Download citation
DOI: https://doi.org/10.1007/978-3-030-68204-0_7
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-68203-3
Online ISBN: 978-3-030-68204-0
eBook Packages: MedicineMedicine (R0)